Delivery Order SPE2DB22D2009-SPE2DB25FL6AV
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,357.64 firm fixed price delivery order is for the supply of 4,566,660,824 Valsartan-HCTZ 160-12.5 mg tablets, which are used to treat high blood pressure. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award, with a ceiling value of $1,588.86, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the supply of pharmaceutical products, including medications such as Amlodipine-Valsartan-Hydrochlorothiazide 10-160-25 mg in 30-count packages. The contract is not set-aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,127.56 firm-fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive...
This federal contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,040.73 firm-fixed-price delivery order is for the supply of valsartan-hydrochlorothiazide 80-12.5 mg tablets, a common medication used to treat high blood pressure. The contract has a June 2024 completion date and is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distribution...
This federal contract award, valued at $2,384.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of Valsartan-HCTZ 160-12.5 mg tablets, which are used to treat high blood pressure. The contract has an ultimate completion date of March 21, 2024 and is a firm fixed-price contract. The award was not designated with a set-aside requirement,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,252.52, is for the delivery of valsartan-HCTZ 320-25 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 320-25 mg tablets. The $6,361.52 firm fixed-price delivery order contract has an ultimate completion date of October 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for...
This federal contract award, valued at $3,959.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of Amlodipine-Valsartan 10-160 mg tablets, a cardiovascular medication, to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,222.53 firm fixed-price delivery order is for the supply of 90-count bottles of the blood pressure medication Valsartan-HCTZ 320-25 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical division, which serves...
This federal contract award, valued at $11,987.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of amlodipine, valsartan, and hydrochlorothiazide tablets, a cardiovascular medication, with a completion date of May 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...